Feasibility of Weekly Electronic Health Record-Embedded Patient-Reported Outcomes for Patients Starting Oral Cancer-Directed Therapy.

Autor: Doolin JW; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Haakenstad EK; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Neville BA; Center for Surgery and Public Health, Brigham and Womens' Hospital, Boston, MA., Lipsitz SR; Center for Surgery and Public Health, Brigham and Womens' Hospital, Boston, MA., Zhang S; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Cleveland JLF; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Hiruy S; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Hassett MJ; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Revette A; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY., Basch E; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., McCleary NJ; Department of Medical Oncology, Gastrointestinal Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300043.

Barriers to Electronic Patient-Reported Outcome Measurement Among Patients with Cancer and Limited English Proficiency.

Autor: Garcia Farina E; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rowell J; University of Virginia, Charlottesville., Revette A; Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, Massachusetts., Haakenstad EK; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cleveland JLF; Information & Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Allende R; Social Work, Dana-Farber Cancer Institute, Boston, Massachusetts., Hassett M; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schrag D; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., McCleary NJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publikováno v: JAMA network open [JAMA Netw Open] 2022 Jul 01; Vol. 5 (7), pp. e2223898. Date of Electronic Publication: 2022 Jul 01.